Delivery Order SPE2DB22D1106-SPE2DB25FEZY0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, valued at $2,252.20 under a firm fixed-price contract structure. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a $2,259.24 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,216.96 to supply Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,093.98 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency has awarded a delivery order totaling $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This contract is not set-aside and was competitively awarded to the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,644.86 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays. This firm fixed-price contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valtoco 5 mg nasal sprays, with a ceiling value of $5,028.35. This competitively awarded, firm fixed-price delivery order is set to conclude by September 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZY0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,309.22 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of July 28, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on July 26, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical pharmaceutical products and medical supplies to federal defense and military healthcare systems through its expansive DLA contract portfolio. Valtoco is a FDA-approved nasal spray formulation used for acute seizure management, aligning with the company's demonstrated capability to deliver specialized pharmaceutical commodities across multiple therapeutic domains. This delivery order exemplifies the company's role as a key vendor within the Defense Health Agency's medical supply chain, fulfilling specific medication requirements through flexible contract mechanisms that support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/26/25 |